Will Korea's New Government Create Strong Biohealth Nation?

Focus On Single 'Control Tower,' Rapid Reimbursement

 
• By Jung Won Shin

The health-related policies of South Korea's new government and how they may affect the pharma industry were dissected at a recent forum in Seoul. 

Hyun Wook Kim, CEO of Hyun & Partners Korea
New Korean Government’s Pro-Industry Stance Raises Biopharmas’ Growth Hopes

More from South Korea

More from Asia